Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113-08113 LungTech phase II trial results
J Thorac Oncol 2024 May 22;[EPub Ahead of Print], A Levy, S Adebahr, C Hurkmans, M Ahmed, S Ahmad, M Guckenberger, X Geets, Y Lievens, M Lambrecht, N Pourel, V Lewitzki, K Konopa, K Franks, R Dziadziuszko, F McDonald, C Fortpied, E Clementel, B Fournier, S Rizzo, C Fink, O Riesterer, H Peulen, N Andratschke, A McWilliam, E Gkika, T Schimek-Jasch, AL Grosu, C Le Pechoux, C Faivre-Finn, U NestleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.